UK Health-AI Rulebook in Formation — Timing Hook for UK Healthcare Outreach
The Medicines and Healthcare products Regulatory Agency (MHRA) is working on a new national commission to regulate Artificial Intelligence (AI) in the healthcare sector, with the aim of having a statutory framework in place by mid-2026. For healthcare executives and decision-makers in Canada and the UK, this development raises significant concerns about capability risk, governance risk, and liability risk.
Capability risk arises from AI systems that fail to do what was promised or claimed. In the healthcare sector, inaccurate diagnosis, misaligned treatment, and patient harm are just a few of the potential consequences. The MHRA’s new commission aims to address this by establishing standards for AI system development, testing, and deployment in clinical settings.
Governance risk stems from boards, regulators, and courts asking questions about how AI decisions were made when they fail or go wrong. Healthcare organisations may struggle to provide satisfactory answers, leading to reputational damage, financial loss, and even legal action. The new commission’s focus on establishing a regulatory framework is essential in helping healthcare executives develop robust governance processes for AI decision-making.
Liability risk emerges from the organisation’s accountability for what its AI does and says. Healthcare providers may face lawsuits or fines if AI decisions result in adverse outcomes. By ensuring that AI systems meet safety and efficacy standards, the MHRA’s new commission can help mitigate this risk.
To navigate these risks prudently, healthcare organisations should take immediate action by:
1. Conducting thorough assessments of vendors’ claims about their AI solutions
2. Ensuring internal governance processes align with the expected regulatory framework
3. Developing robust compliance programs to address potential liability issues
However, these steps are challenging for many healthcare providers due to vendor information asymmetry and internal teams being too close to the decision-making process. This is where independent help can make a critical difference.
Straven & Co offers AI validation services that examine decisions before they are acted on by independently testing proposed solutions against clients’ real operations, people, governance obligations, legal exposure, and regulatory requirements. Our plain verdict — proceed, proceed with conditions, or do not — provides organisations like yours with the confidence to commit resources to AI solutions while minimising risk.
Straven & Co examines AI decisions before they are acted on: stravenandco.com.